medline.ch Respirationstrakt Neoplasie

	Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer. Discov Oncol Jiang X, Zheng M, Zhang L, Xu D, Cheng J, Deng H, Wei C, Xian J, Xu F, Maghsoudloo M, Li D, Ma W, Fu J. PMID: 41941024 [PubMed - as supplied by publisher]
	Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study. Future Oncol Oduah EI, Zhang T, Jung SH, Stinchcombe TE, Ready N, Crawford J, Clarke JM, Gray JE, Antonia SJ. PMID: 41940540 [PubMed - as supplied by publisher]
	Accuracy of Radiomics-Based Machine Learning for Predicting Risk of Recurrence in Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis. J Med Internet Res Wu J, Zhang Y, Wang J, Chen C, Hu S, Chen W. PMID: 41940422 [PubMed - indexed for MEDLINE]
	Decoding macrophage heterogeneity in the pulmonary fibrosis lung cancer transition. Front Immunol Yu H, Zhao M, Li Q, Zhang Y. PMID: 41939908 [PubMed - indexed for MEDLINE]
	Case Report: A case of diabetes mellitus and pneumonitis induced by envafolimab treatment in small cell lung cancer. Front Immunol Li Y, Wang H, Xing G, Guo X, Yi S. PMID: 41939902 [PubMed - indexed for MEDLINE]
	Targeted therapies in non-small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management. Front Pharmacol Nardin S, Vezzoli F, Cognolato G, Mollace R, Ramella Pollone B, Biello F, Cao D, Tagliamento M, Sarocchi M, Pagnesi M, Verdoia M, Conte B, Grisanti S, Genova C, Gennari A, Nardin M. PMID: 41939827 [PubMed]
	Correction: Prevalence and survival implications of CT-defined low skeletal muscle mass in lung cancer: a systematic review and meta-analysis. Front Oncol Tao Z, Yi B, Wu Q, Luo Y, Zhou C. PMID: 41939477 [PubMed]
	Prevalence and survival implications of CT-defined low skeletal muscle mass in lung cancer: a systematic review and meta-analysis. Front Oncol Tao Z, Yi B, Wu Q, Luo Y, Zhou C. PMID: 41939462 [PubMed]
	Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic MET exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study. Lancet Reg Health West Pac Yu Y, Guo Q, Zhang Y, Fang J, Zhong D, Liu B, Pan P, Lv D, Wu L, Zhao Y, Li J, Liu Z, Liu C, Su H, Fan Y, Zhang T, Liu A, Jin B, Wang Y, Zhou J, Zhang Z, Ran F, Song X, Shi MM, Su W, Lu S, study group. PMID: 41938023 [PubMed]
	Tumor size as a key determinant of treatment strategy and prognosis in stereotactic body radiotherapy for pulmonary metastases: a retrospective study. Rep Pract Oncol Radiother Okuma K, Kashihara T, Inaba K, Takahashi K, Sakuramachi M, Nagao A, Yoshiba A, Kobori A, Gao T, Nakamura S, Igaki H. PMID: 41937881 [PubMed]
	Integrated Strategies for Nursing and Rehabilitation in Lung Cancer Patients. Asia Pac J Clin Oncol Fu Q, Zhao Z, Yin D. PMID: 41937719 [PubMed - as supplied by publisher]
	Efficacy and safety of albumin-bound paclitaxel combined with simvastatin in the second-line treatment of small cell lung cancer: a phase II randomized controlled trial. BMC Med Guan M, Zhao W, Zhang W, Chen X, Huang R, Liu X, Li Y, Wang H, Zhao L, Xu K, Ye L, Chen Z, Liu Y, Zhang Q, Ji H, He Y. PMID: 41937137 [PubMed - as supplied by publisher]
	Lung cancer segmentation Using the Att-U-Net Model on PET-CT Images. Radiography (Lond) Ayadi A, Hammami I, Mdimagh O. PMID: 41935472 [PubMed - as supplied by publisher]
	Resting energy expenditure as a predictor of immune checkpoint inhibitors response in older patients with non-small cell metastatic lung cancer: A pooled analysis of two prospective cohort studies. Clin Nutr Pautas M, Boudou-Rouquette P, Jouinot A, Chahwakilian A, Arrondeau J, Fabre E, de Percin S, Huillard O, Ulmann G, Damotte D, Mansuet-Lupo A, Wislez M, Alexandre J, Canouï-Poitrine F, Paillaud E, Goldwasser F. PMID: 41934871 [PubMed - as supplied by publisher]
	Dual-layer spectral CT for predicting spread through air spaces in lung adenocarcinoma: a dual-center study. Eur Radiol Fang C, Cui Y, Li F, Li X, Qiao Y, Yang X. PMID: 41934495 [PubMed - as supplied by publisher]
	Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee. J Thorac Oncol McMahon RA, Lee Min Chua K, Faivre-Finn C, Filippi AR, Hendriks LEL, John T, Liu SV, McDonald F, Popat S, Saw SPL, Munoz-Schuffenegger P, Velcheti V, Louie AV, Siva S. PMID: 41934464 [PubMed - as supplied by publisher]
	Real-world efficacy of first-line immunochemotherapy combined with thoracic radiotherapy in elderly patients with extensive-stage small cell lung cancer: a single-center retrospective study. Future Oncol Sun F, Lu S, Wu M, Yu J, Chen D. PMID: 41934389 [PubMed - as supplied by publisher]
	Cost-effectiveness analysis of tepotinib vs capmatinib as subsequent therapy in MET exon 14-mutated non-small-cell lung cancer. Lung Cancer Manag Liu M, Zhong L, Liu T. PMID: 41934258 [PubMed]
	The role of germline mutations in non-small cell lung cancer: A systematic review of emerging genetic drivers and clinical implications. Crit Rev Oncol Hematol Gentile G, Gelibter A, De Marchis L, Pappalardo L, Capasso C, Giusti R, Botticelli A, Mazzuca F, Santini D, Siringo M. PMID: 41933854 [PubMed - as supplied by publisher]
	Pulmonary Microbiota is a Hidden Link between Lung Cancer Development and Microenvironment: Potential for Future Immune Therapeutic Strategies. Crit Rev Oncol Hematol Rao X, Zhou R, Li W, Chai X, Zhang H. PMID: 41933853 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 158631

Seite 1 von 7932



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung